Evidence map›Paper›PMID 31835640›Full record

ArticleInternational journal of molecular sciences2019

Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT

Motohiro Okada, Ruri Okubo, Kouji Fukuyama

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Serotonin in Health and Disease.International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Motohiro OkadaDepartment of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University; Tsu 514-8507, Japan.ORCID 0000-0002-9025-2548
Ruri OkuboDepartment of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University; Tsu 514-8507, Japan.
Kouji FukuyamaDepartment of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University; Tsu 514-8507, Japan.
Mie University · JP

Funding

Japan Society for the Promotion of Science 19K08073
6 · The paper itself

Abstract

Vortioxetine is a novel, multimodal antidepressant with unique targets, including the inhibition of the serotonin transporter (SET), of serotonin 5-HT

Indexed as

AnimalsCitalopramgamma-Aminobutyric AcidMalePrefrontal CortexRatsReceptor, Serotonin, 5-HT1AReceptors, Serotonin, 5-HT3Selective Serotonin Reuptake InhibitorsSerotoninVortioxetineCitalopramgamma-Aminobutyric AcidReceptor, Serotonin, 5-HT1AReceptors, Serotonin, 5-HT3Selective Serotonin Reuptake InhibitorsSerotoninVortioxetinedepressionescitalopramGABAmicrodialysisMK801ratserotoninvortioxetine

Identifiers

PMID31835640
PMCPMC6940928
OpenAlexW2996410628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.